Company Search:
Advanced Search
Sponsored Links
Hisamitsu Pharmaceutical Co Inc Company Snapshot
Hisamitsu Pharmaceutical Co Inc operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hisamitsu Pharmaceutical Co Inc with three other companies in this sector in Japan: Daito Pharmaceutical Company Limited (2016 sales of 36.37 billion Japanese Yen [US$322.97 million] of which 60% was Drug Substance), Kissei Pharmaceutical Company Limited (71.29 billion Japanese Yen [US$633.09 million] of which 87% was Pharmaceutical Products), and Fuji Pharma Company Limited (34.23 billion Japanese Yen [US$303.95 million] of which 100% was Pharmaceutical Business).

Sales Analysis. Hisamitsu Pharmaceutical Co Inc reported sales of ¥161.85 billion (US$1.44 billion) for the fiscal year ending February of 2016. This represents an increase of 3.3% versus 2015, when the company's sales were ¥156.74 billion. Sales at Hisamitsu Pharmaceutical Co Inc have increased during each of the previous five years (and since 2011, sales have increased a total of 18%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Hisamitsu Pharmaceutical Co Inc
  Stock Performance Chart for Hisamitsu Pharmaceutical Co Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 6,040.00
(Figures in Japanese Yen)
1 Week 0.0%   13 Weeks 9.0%  
4 Weeks 17.3%   52 Weeks 23.1%  
Hisamitsu Pharmaceutical Co Inc Key Data:
  Ticker: 4530 Country: Japan
  Exchanges: TYO OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 161,852,000,000
(Year Ending Jan 2017).
Employees: 2,900
  Currency: Japanese Yen Market Cap: 505,339,348,200
  Fiscal Yr Ends: February Shares Outstanding: 83,665,455
  Share Type: Common Closely Held Shares: 17,027,213
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.